Elevation Oncology, Inc. - Common stock (ELEV)

Elevation Oncology Inc is a biopharmaceutical company focused on developing targeted therapies for patients with genomically defined cancers

The company is dedicated to understanding the unique genetic drivers of these diseases and aims to create innovative treatment options that address unmet medical needs. By leveraging its expertise in precision medicine and oncology, Elevation Oncology works to advance its clinical pipeline, providing hope to patients with rare and challenging cancer types through personalized and effective therapeutic strategies.